chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had headache that started right after the vaccination was given; Patient felt dizziness; Within 24 hours of receiving the Moderna Covid-19 booster dose the patient fainted.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of SYNCOPE (Within 24 hours of receiving the Moderna Covid-19 booster dose the patient fainted.) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 043L20A and 025J20-2A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Oct-2021, the patient experienced HEADACHE (Patient had headache that started right after the vaccination was given) and DIZZINESS (Patient felt dizziness). In October 2021, the patient experienced SYNCOPE (Within 24 hours of receiving the Moderna Covid-19 booster dose the patient fainted.) (seriousness criterion medically significant). The patient was treated with Physical therapy for Dizziness. In June 2022, HEADACHE (Patient had headache that started right after the vaccination was given) had resolved. At the time of the report, SYNCOPE (Within 24 hours of receiving the Moderna Covid-19 booster dose the patient fainted.) and DIZZINESS (Patient felt dizziness) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient did not had adverse reactions after Dose 1 and dose 2. Patient received medication for the headache.; Reporter's Comments: Company comment: This spontaneous case concerns an 82-year-old female patient with no reported medical history who experienced the unexpected serious (medically significant) event of Syncope which occurred within 24 hours of receiving a dose of mRNA-1273 vaccine received as booster dose in COVID 19 vaccination series. Event was ongoing at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. No pertinent medical history, drug reactions or allergies and concomitant medications were reported. On unspecified dates, the unspecified number of patients received improperly stored doses of GARDASIL 9 (lot #, expiration date, dose, route of administration and indication were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax & devel a fever which persisted as of 5JAN98;pt was hosp for unspecified reasons;
Erythema and sli swelling at site of injection of prevnar; Tylenol as needed.
Info has been received from a physician concerning an 8 year old male with no medical history or allergies who on 1/25/99 was vaccinated with a dose of varicella virus vaccine live (lot 627876/1241H). The physician reported that on 1/28/06, the pt developed 40-50 pinpoint lesions that came in crops and became vesicular. The pt was also reported to have had a runny nose. Unspecified medical attention was sought and the pt was prescribed Benadryl. No lab/diagnostic tests were performed. At the time of this report, the pt was recovering. Additional info has been requested.
partial dose was received; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th August 2021, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional case details were provided as follows: The case was reported by the patient for herself. The reporter was a registered nurse (RN), she received a dose of Shingrix to be administered independently from her hospital pharmacy.  The reporter stated a coworker attempted to administer the dose to her but only a partial dose was received after the needle separated from the Tip-Lok syringe which led to incomplete course of vaccination.  The reporter stated that, the syringe used was not a Glaxosmithkline product.  The reporter did not wish to identify the coworker.  The reporter consented to follow up.
numbness, pins & needles sensation in both hands & forearms starting 13JUL93 & cont on 15JUL93; 28DEC93 sl residual numbness rt hand;
About 8 hours after receiving my second dose, I started to feel very foggy, experience severe joint pain, dizziness, vertigo, confusion, memory loss of recent events, I have blackouts and feel fatigued. I would have moments where I would just fall asleep and wake up an hour later, in shock that I slept that long. This would happen multiple times throughout the day. A few months after my vaccine, I started to experience high blood pressure and tremors in my fingers. This is still occurring 1 year after receiving the vaccine. About three months ago, I started to experience constant and shooting eye pain. My vision has gotten a little worse. I previously had RLS and it has become worse.
Severe headache; Nausea; feels like when she catches a cold; Throat feels funny; Voice is scratchy; Cheeks flush/rosy; Feels sluggish; Iron/chemical taste in mouth; Feels like she does when she's catching a cold; Symptoms getting worse as the day goes on; Arm was really sore; A spontaneous report was received from a consumer concerning a 41 year old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm, severe headache, throat feels funny, voice was scratchy, cheeks flush/rosy, nausea, feels sluggish, an iron/chemical taste in the mouth and feels like she was catching a cold.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 04 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch No: 011J20A) in the left arm for prophylaxis of COVID-19 infection.  On 04 Jan 2021, After receiving the vaccine, she stated that her arm was really sore. On 05 Jan 2021, the patient woke up with a severe headache. The patient experienced sore arm, severe headache, throat feels funny, voice was scratchy, cheeks flush/rosy, nausea, feels sluggish, an iron/chemical taste in the mouth and feels like she was catching a cold. The patient stated that the symptoms seem to be getting worse as the day goes on. The patient also stated she was in contact with several COVID positive individuals before being vaccinated but two separate COVID tests came back negative, however she was feeling sick the week prior to getting vaccinated. Treatment for the event included migraine medication.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events experienced sore arm, throat feels funny, severe headache, voice is scratchy, cheeks flush/rosy, nausea, feels sluggish, an iron/chemical taste in the mouth and feels like she's catching a cold was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
rheumatologic reaction and now has inflammatory arthritis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000004240 (Novavax).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose-1, Manufacturer Unknown), for Covid-19 immunization; Covid-19 vaccine (Dose-2, Manufacturer Unknown), for Covid-19 immunization. The following information was reported: RHEUMATOID ARTHRITIS (medically significant), outcome "unknown", described as "rheumatologic reaction and now has inflammatory arthritis".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
8 hours after vaccination developed chills, fever 101, dizziness, c/o short of breath, uneasy feeling. Lasted 1 1/2 hours and went away with no interventions.
Information has been received from a registered nurse concerning a female in her 20's who was vaccinated with her first dose of 0.5 ml Gardasil via injection.  The patient fainted, fell down and knocked out her two front teeth after getting the first dose of Gardasil.  The patient was referred to a dentist.  No further information was provided.  Additional information has been requested. 07/08/08 Initial and follow-up information has been received from a registered nurse concerning a 20 year old female student, who on 27-NOV-2007 at 13:20 was vaccinated IM in the left deltoid with her first dose of 0.5 ml GARDASIL (Lot# 659435/1269U). On 27-NOV-2007 at 13:30 the patient fainted, fell down and knocked out her two front teeth after getting the first dose of GARDASIL. The patient was referred to a dentist. The patient was seen and treated by the dentist. No laboratory diagnostics were performed. The patient recovered on 27-NOV-2007. Additional information is not expected.
I had elevated calcium screening score. I had a CT scan of arteries that showed I have lesions on my LED and RCA 70%. The cardiologist that I was referred to scheduled me to have stents put in that I will be going in to have done on 10/28/2022. Cardiologist is confident the stents will take care of the blockage and I will recovery nicely.
patient began spitting up globs of mucus 13 hours after vaccine and continued for14 hours Patient died 2-4 hours later
No adverse events pt was given a PEDS dose of Pfizer for his second dose his mother was notified and aware he will need to come back for the other part of the dose for his series to be completed.
My daughter who lives in another country arrived home 16DEC2022 mon 18DEC2022 and became symptomatic on 19DEC2022 I became symptomatic 19DEC2022 and tested positive on a home test and on 20DEC2022 tested positive with a PCR test. I started with laryngitis on the morning of 20DEC2022. I developed malaise and other symptoms and was relatively well by 21DEC2022.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 41-year-old female. Neither medical history nor concomitant medications were reported. On 27-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 12-May-2009: Product Complaint Investigation results.
Injection to left deltoid on 5/14/2021.  Patient developed paresthesias of the entire left upper extremity from shoulder to finger tips.  Paresthesias have been unchanged for the past week.
Immediately after vaccines were given (Adacel, Menactra, and HPV 1/3) pt. c/o dizziness and weakness.  After lying down for 15 min, pt. ambulated out of office.  Next morning, mom phoned and reported that pt. c/o dizziness while in the shower, "saw stars" and black.  Pt. climbed out of shower and sat on floor.  All day, main complaint of headache.
On 05/19/21 experience slur speech with words. I see and think of the word/words clearly but when pronunciation  they came out incorrect .  ( Irritated slurred) no pain . It lasted several days not until Monday  May 24,  2021. I felt normal.
Started with a rash on face - small red round spots, some raised, some flat. Rash progressed down trunk and all 4 extremities.  Ran fever 100-101 later that night, around 8 pm, rash lasted 5 days.
Pt. complained of dysphagia 10 minutes after vaccine administration.   S/s started at 4:45 pm.  She reported tightness in throat and difficulty breathing and swallowing.  4:55 pm 0.3 mg. (1:1000 dilution) Epinephrine administered IM pt's. right deltoid. 5:10 pm: VS: BP: 150/80, apical HR 76 and regular.   First responders arrived to take over care. 5:15 pm: Ambulance crew arrived. 5:25 pm: Transported from clinic to hospital.    3/2/21: T/c to pt.  3/3/21: Pt. called back to report she had no  localized or systemic side effects she felt was from the vaccine.  The hospital released her at 10 pm on 2/26/21.
A week after receiving the shot, a large and itchy red welt appeared on my arm (same arm as the injection, but not at the injection site). The welt disappeared, but then my upper arm swelled for 48 hours -- it was red and extremely warm to the touch. There was some mild pain and lots of tingling and tightness.
after receiving vaccine the patient's arm was swollen and painful and tender to touch for the following week, (06/12/23-6/18/23) and currently it is red and itchy at the site of injection. (06/19/23)
Narrative: Headache, HA, body ache, feeling tired, feeling hot/cold, vaccine admin site with hard knot "that's growing"
Covid arm appeared on Day 9 after the first injection. Large red patch around injection site, slightly raised, very itchy. Still there today. The site has been itchy since the first shot. Had initial redness that disappeared after a few hours. Reappeared with a vengeance Day 9. Have also been fatigued and my arm and shoulder have ached since receiving the vaccine. I called my dermatologist, but she had never heard of this condition. However, it's showing up more and more on the internet. Because of the lingering effects, I am not certain I will get the second dose. I know many people who've received the Pfizer vaccine, and none have experienced what I have.
Mild symptoms the next day (12/31/2020): fatigue, low grade headache minor injection site soreness. I took Ibuprofen, rested, had lots of liquids, and was fine the day after (01/01/2021) No other symptoms until exactly one week later (01/06/2021). I noticed the injection site on my left arm was itching and a bit sore. A 5"x3" red rash appeared at injection site. I took one Acetaminophen PM that night. The red rash is still there. These appear to be minor reactions but the red rash is never one I have had before with any vaccinations. It seems strange it didn't appear until a week later. No difference in skin lotion I have used. I wanted to report effects for data collection purposes since it is a new/emergency vaccine.
Received H1N1 inactivated vaccine 0.5 ml IM to Rt. deltoid at 2:10 PM.  At 6:00 PM that night developed temperature of 100.2 with body aches.  Took 2 ASA and called her doctor. By 3:00 AM felt fine.  No further symptoms.
About 3 minutes after getting the shot, patient presented with seizure-like reaction but  immediately recovered ( less than a minute ). However he did not recognize his whereabouts but was able to realize it in a few seconds. Initial  blood pressure taken was 77/53 , pulse 72 . We were calling 911 but he refused .  Patient was awake , alert when he left the facility.
pt got pfizer vaccine around at 7pm. Then fell down from chair less than 5 min. Pt drank a cup of water then fell down again. An eyewitness said his head was not hit on the floor. EMS came and check BP, O2. Ask questions and wait 30-40 minutes EMS left w/o pt. Pt. left w/ security gurad
After receiving his booster dose, patient lost conciousness and fell out of his chair.  He remained unconcious for about 10 sec.  He regained alterness but was still very "woozy" feeling.
Headache, nausea, blurred vision lasting about 5 1/2 days - fully recovered on day 6
Broke out in welts on the right side of my torso and butt on day 3. Chilled for 3 days and couldn't get warm. The welts were the size of quarters
Patient presented with progressive numbness of his upper and lower extremites after receiving Shingrix vaccine. Patient was admitted to the hospital and evaluated by neurology.  Patient recieved IVIG for  diagnosis of Guillain-Barre.
Large Local reaction (erythema, some induration), mild low grade temp 100.6 on day of vaccine.
When given the injection I got a burning sensation in my chest and stomach that lasted 1 hour; When given the injection I got a burning sensation in my chest and stomach that lasted 1 hour; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Sep2021 16:30 (Lot number: FC3184) at the age of 48 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Brain injury" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "Food and drug allergies" (unspecified if ongoing), notes: known allergies: Food and drug allergies; "Food and drug allergies" (unspecified if ongoing), notes: known allergies: Food and drug allergies. There were no concomitant medications. The following information was reported: CHEST PAIN (non-serious), DYSPEPSIA (non-serious) all with onset 18Sep2021, outcome "recovered" (Sep2021) and all described as "When given the injection I got a burning sensation in my chest and stomach that lasted 1 hour". Therapeutic measures were not taken as a result of chest pain, dyspepsia.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was not Hospitalization prolonged. Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
L thigh streaky erythema warm to touch. Dx cellulitis given Augnentin 300mg x 7 days. Seen by physician 8/1/02. Follow-up 1 day.
Little pain in stomach muscle; cramping; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Little pain in stomach muscle) and MUSCLE SPASMS (cramping) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced ABDOMINAL PAIN UPPER (Little pain in stomach muscle) and MUSCLE SPASMS (cramping). At the time of the report, ABDOMINAL PAIN UPPER (Little pain in stomach muscle) and MUSCLE SPASMS (cramping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The reported was not sure if the adverse events were acid reflux related. Concomitant medication and treatment information were not reported.    Reporter did not allow further contact
This case was reported by a physician via call center representative and described the occurrence of chills in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, several hours after receiving SHINGRIX, the patient experienced chills, sweating, nausea, fatigue and feeling bad. On an unknown date, the outcome of the chills, sweating, nausea, fatigue and feeling bad were recovered/resolved. It was unknown if the reporter considered the chills, sweating, nausea, fatigue and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received a dose of SHINGRIX 2.5 months ago around 3 pm in the right deltoid and developed the listed side effects later that night and they lasted about 36 hours.
extreme chills 1 hour after injection on 1/22/21.  Chills and fever of 100.9 the day after shot.  1/26/21, still having mild cold symptoms, congestion, sore throat
After vaccine on 2/3/23, patient experienced redness and pain at injection site. Following day self reported fever. Seen in clinic on 2/8/23 and started on a course of cephalexin for increased redness and swelling. On 2/10/23 patient was admitted to the hospital and treated with vancomycin therapy. Discharged on 2/12 with additional 5 day course of Bactrim.
Woke with swollen red and draining eyes, began having difficulty breathing and felt like something heavy on chest, nasal congestion, wheezing in lungs, and muscle aches all over. Received albuterol treatment.
Stroke  No pre-existing conditions prior to date of stroke. Two (2) day hospital stay and then released.
Arm redness and swelling, fever (over 102 degrees F), body aches, nausea, headache, dizziness, trouble staying awake, resting heart rate over 100, weakness. Symptoms lasted 36 hours. Doctor advised to take Tylenol for fever and Benadryl for other side effects. Called doctor's office 06/24/2015 at 09:17 AM.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 03-OCT-2017, the patient was vaccinated with PNEUMOVAX 23, 1 dose, lot# reported as R73811, expiration date: 18-MAY-2018, for prophylaxis (route of administration was not reported). Other suspect therapies included ROTATEQ 1 dose, orally, lot# M038717, expiration date: 26-SEP-2019, for prophylaxis. No adverse effects were reported. The vaccines experienced a temperature excursion between 32 Fahrenheit degrees and 35 Fahrenheit degrees within the average temperature of 33.1 Fahrenheit degrees for 14 hours. Digital Data Logger was not involved. There was no previous temperature excursion. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1710USA002363.
pfizer for 5-12 years old was administered, but pt was 3 years old so she needed a pfizer instead. previous coworker took out the vial and dilution and stated the time that needed to be diluted. pt and family were waiting for at least 30 minutes as we did not see their paper so we did not prepare the vaccine. I rushed the process and diluted the vial as the consent form stated the vaccine was out and ready to be diluted at a certain time. once administered, i realized it was the incorrect vaccine while documenting. informed doctor of the day, primary care provider for pt, and informed mom about the event. after waitinf 15 minutes to check, pt was not experiencing any and advised when to call when experiencing.